Durec­t's non-opi­oid painkiller brush­es aside check­ered past, gain­ing FDA ap­proval in shoul­der surg­eries

Af­ter a long and of­ten bumpy ride, Durect’s non-opi­oid painkiller has re­ceived the FDA’s en­dorse­ment.

US reg­u­la­tors ap­proved the sus­tained-re­lease bupi­va­caine so­lu­tion for use up …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.